Skip to main content

Advertisement

SpringerLink
Log in

Cancer-specific methylation in the BRCA1 promoter in sporadic breast tumours

  • Letter to the Editor
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Catteau A, Harris WH, Xu CF, et al. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 1999;18:1957–65.

    Article  PubMed  CAS  Google Scholar 

  2. Rice JC, Ozcelik H, Maxeiner P. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis. 2000;21:1761–5.

    Article  PubMed  CAS  Google Scholar 

  3. Hedenfalk I, Duggan D, Chen Y. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344:539–48.

    Article  PubMed  CAS  Google Scholar 

  4. van’t Veer LJ, Dai H, Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–6.

    Article  Google Scholar 

  5. Rice JC, Massey-Brown KS, Futscher BW. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene. 1998;17:1807–12.

    Article  PubMed  CAS  Google Scholar 

  6. Xu CF, Chambers JA, Solomon E. Complex regulation of the BRCA1 gene. J Biol Chem. 1997;272:20994–7.

    Article  PubMed  CAS  Google Scholar 

  7. Thakur S, Croce CM. Positive regulation of the BRCA1 promoter. J Biol Chem. 1999;274:8837–43.

    Article  PubMed  CAS  Google Scholar 

  8. Brabender J, Usadel H, Metzger R, et al. DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. Clin Cancer Res. 2003;9:223–7.

    PubMed  CAS  Google Scholar 

  9. Peters I, Rehmet K, Wilke N, et al. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis. Mol Cancer. 2007;16:49.

    Article  Google Scholar 

  10. Snell C, Krypuy M, Wong EM, et al. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res. 2008;10:R12.

    Article  PubMed  Google Scholar 

  11. Breast Cancer Information Core Database 2007: http://research.nhgri.nih.gov/bic/

  12. Malone CS, Miner MD, Doerr JR, et al. CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing. Proc Natl Acad Sci USA. 2001;98:104040–10409.

    Article  Google Scholar 

  13. Teng C, Gladwell W, Ralphiou I, et al. Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals. 2004;17:317–23.

    Article  PubMed  CAS  Google Scholar 

  14. Chan QKY, Khoo US, Chan KYK, et al. Promoter methylation and differential expression of π-class glutathione s-transferase in endometrial carcinoma. J Mol Diagn. 2005;7:8–16.

    Article  PubMed  CAS  Google Scholar 

  15. Ramsahoye BH, Biniszkiewicz D, Lyko F, et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci USA. 2000;97:5237–42.

    Article  PubMed  CAS  Google Scholar 

  16. Grandjean V, Yaman R, Cuzin F. Inheritance of an epigenetic mark: the CpG DNA methyltransferase 1 is required for de novo establishment of a complex pattern of non-CpG methylation. PLoS ONE. 2007;2:e1136.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Singapore National Medical Research Council (NMRC grant: R176-000-056-213).

Author information

Authors and Affiliations

  1. Cancer Science Institute (CSI) Singapore, National University of Singapore, 28 Medical Drive, Centre for Life Sciences (CeLS), Singapore, 117456, Singapore

    Azhar B. Ali

  2. Department of Surgery, National University Hospital, Singapore, Singapore

    Philip T. C. Iau

  3. Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Jen-Hwei Sng

Authors
  1. Azhar B. Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip T. C. Iau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jen-Hwei Sng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Azhar B. Ali.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ali, A.B., Iau, P.T.C. & Sng, JH. Cancer-specific methylation in the BRCA1 promoter in sporadic breast tumours. Med Oncol 28, 64–66 (2011). https://doi.org/10.1007/s12032-010-9438-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9438-y

Keywords

Search

Navigation